Addex Therapeutics} stock has undergone multiple analysts rating changes in the recent past. Addex Therapeutics Upgraded by Zacks Investment Research on 10-11-21. In a note to investors, the firm issued a new rating of Hold. The analysts previously had rating of Sell.
View More Addex Therapeutics (ADXN) Upgraded by Zacks Investment Research to Hold
Quarterly, annual earnings. See the latest EPS estimates vs Actual and surprise it caused. Stock Market Daily has their analysis…
View More Does Earnings Surprise History Hold Any Clue for NYSE:PRTY, NASDAQ:QTNT, NASDAQ:ADXN, NASDAQ:CLMT
Quarterly, annual earnings. See the latest EPS estimates vs Actual and surprise it caused. Stock Market Daily has their analysis…
View More thoughts on these estimates, before EPS results? NASDAQ:BLDP, NASDAQ:NEON, NASDAQ:RAPT, NASDAQ:ADXN
Quarterly, annual earnings. See the latest EPS estimates vs Actual and surprise it caused. Stock Market Daily has their analysis…
View More numbers crunched for you before earnings results NASDAQ:STRL, NASDAQ:ADXN, NASDAQ:PTGX, NYSE:BLL
